BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28084903)

  • 1. Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish population.
    Hallberg P; Persson M; Axelsson T; Cavalli M; Norling P; Johansson HE; Yue QY; Magnusson PK; Wadelius C; Eriksson N; Wadelius M
    Pharmacogenomics; 2017 Feb; 18(3):201-213. PubMed ID: 28084903
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Mu G; Xiang Q; Zhang Z; Liu C; Zhang H; Liu Z; Pang X; Jiang J; Xie Q; Zhou S; Wang Z; Hu K; Wang Z; Jiang S; Qin X; Cui Y
    Pharmacogenomics; 2020 Jun; 21(9):601-614. PubMed ID: 32397904
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of polymorphisms of the renin-angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough.
    Mukae S; Itoh S; Aoki S; Iwata T; Nishio K; Sato R; Katagiri T
    J Hum Hypertens; 2002 Dec; 16(12):857-63. PubMed ID: 12522467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic predictors of angiotensin-converting enzyme inhibitor-induced cough: the role of ACE, ABO, and BDKRB2 genes.
    Mas S; Gassò P; Alvarez S; Ortiz J; Sotoca JM; Francino A; Carne X; Lafuente A
    Pharmacogenet Genomics; 2011 Sep; 21(9):531-8. PubMed ID: 21832968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three candidate genes and angiotensin-converting enzyme inhibitor-related cough: a pharmacogenetic analysis.
    Zee RY; Rao VS; Paster RZ; Sweet CS; Lindpaintner K
    Hypertension; 1998 Apr; 31(4):925-8. PubMed ID: 9535416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment.
    Rasmussen ER; Hallberg P; Baranova EV; Eriksson N; Karawajczyk M; Johansson C; Cavalli M; Maroteau C; Veluchamy A; Islander G; Hugosson S; Terreehorst I; Asselbergs FW; Norling P; Johansson HE; Kohnke H; Syvänen AC; Siddiqui MK; Lang CC; Magnusson PKE; Yue QY; Wadelius C; von Buchwald C; Bygum A; Alfirevic A; Maitland-van der Zee AH; Palmer CNA; Wadelius M
    Pharmacogenomics J; 2020 Dec; 20(6):770-783. PubMed ID: 32080354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors.
    Lunde H; Hedner T; Samuelsson O; Lötvall J; Andrén L; Lindholm L; Wiholm BE
    BMJ; 1994 Jan; 308(6920):18-21. PubMed ID: 8298346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibitors and cough--a north Indian study.
    Singh NP; Uppal M; Anuradha S; Agarwal A; Rizvi SN
    J Assoc Physicians India; 1998 May; 46(5):448-51. PubMed ID: 11273288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genome-wide association study identifies variants in KCNIP4 associated with ACE inhibitor-induced cough.
    Mosley JD; Shaffer CM; Van Driest SL; Weeke PE; Wells QS; Karnes JH; Velez Edwards DR; Wei WQ; Teixeira PL; Bastarache L; Crawford DC; Li R; Manolio TA; Bottinger EP; McCarty CA; Linneman JG; Brilliant MH; Pacheco JA; Thompson W; Chisholm RL; Jarvik GP; Crosslin DR; Carrell DS; Baldwin E; Ralston J; Larson EB; Grafton J; Scrol A; Jouni H; Kullo IJ; Tromp G; Borthwick KM; Kuivaniemi H; Carey DJ; Ritchie MD; Bradford Y; Verma SS; Chute CG; Veluchamy A; Siddiqui MK; Palmer CN; Doney A; MahmoudPour SH; Maitland-van der Zee AH; Morris AD; Denny JC; Roden DM
    Pharmacogenomics J; 2016 Jun; 16(3):231-7. PubMed ID: 26169577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibitor induced cough in Nigerians.
    Adigun AQ; Ajayi AA
    West Afr J Med; 2001; 20(1):46-7. PubMed ID: 11505887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polygenic risk score for ACE-inhibitor-associated cough based on the discovery of new genetic loci.
    Ghouse J; Tragante V; Muhammad A; Ahlberg G; Skov MW; Roden DM; Jonsdottir I; Andreasen L; Lundegaard PR; Trudsø LC; Banasik K; Brunak S; Ostrowski SR; ; Torp-Pedersen C; Pedersen OV; Sørensen E; Køber L; Iversen K; Thorsteinsdottir U; Thorgeirsson G; Ullum H; Gudbjartsson DF; Mosley JD; Holm H; Stefansson K; Bundgaard H; Olesen MS
    Eur Heart J; 2022 Dec; 43(45):4707-4718. PubMed ID: 35751511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of genetic factors associated with susceptibility to angiotensin-converting enzyme inhibitors-induced cough.
    Grilo A; Sáez-Rosas MP; Santos-Morano J; Sánchez E; Moreno-Rey C; Real LM; Ramírez-Lorca R; Sáez ME
    Pharmacogenet Genomics; 2011 Jan; 21(1):10-7. PubMed ID: 21052031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitors.
    Mahmoudpour SH; Veluchamy A; Siddiqui MK; Asselbergs FW; Souverein PC; de Keyser CE; Hofman A; Lang CC; Doney AS; Stricker BH; de Boer A; Maitland-van der Zee AH; Palmer CN;
    Pharmacogenet Genomics; 2017 Mar; 27(3):112-119. PubMed ID: 28030426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril)-Induced Cough: a Pharmacogenetic Study.
    Luo JQ; He FZ; Wang ZM; Sun NL; Wang LY; Tang GF; Liu MZ; Li Q; Chen XP; Liu ZQ; Zhou HH; Zhang W
    Sci Rep; 2015 Nov; 5():17253. PubMed ID: 26607661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in the neurokinin-2 receptor gene are associated with angiotensin-converting enzyme inhibitor-induced cough.
    Kim TB; Oh SY; Park HK; Jeon SG; Chang YS; Lee KY; Cho YS; Chae IH; Kim YK; Cho SH; Moon HB; Min KU; Kim YY
    J Clin Pharm Ther; 2009 Aug; 34(4):457-64. PubMed ID: 19583679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute adverse reactions associated with angiotensin-converting enzyme inhibitors: genetic factors and therapeutic implications.
    Nikpoor B; Duan QL; Rouleau GA
    Expert Opin Pharmacother; 2005 Sep; 6(11):1851-6. PubMed ID: 16144506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchial hyperreactivity induced by angiotensin converting enzyme inhibitor.
    Goh TC; Ong YY
    Singapore Med J; 1991 Jun; 32(3):183-4. PubMed ID: 1652161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The positive association of cough with angiotensin-converting enzyme inhibitors.
    Just PM
    Pharmacotherapy; 1989; 9(2):82-7. PubMed ID: 2657676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a clinical prediction rule for angiotensin-converting enzyme inhibitor-induced cough.
    Morimoto T; Gandhi TK; Fiskio JM; Seger AC; So JW; Cook EF; Fukui T; Bates DW
    J Gen Intern Med; 2004 Jun; 19(6):684-91. PubMed ID: 15209608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE-inhibitor-induced cough, an adverse drug reaction unrecognised for several years: studies in prescription-event monitoring.
    Kubota K; Kubota N; Pearce GL; Inman WH
    Eur J Clin Pharmacol; 1996; 49(6):431-7. PubMed ID: 8706766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.